Psoriatic arthritis is an inflammatory disease of the joints associated with progressive joint destruction and loss of function. The additional challenge of managing psoriasis can mean patients' needs differ from those associated with other inflammatory joint conditions. This article discusses the goals of drug treatment and physical therapies in terms of minimising symptoms of the disease. In addition, the psychological effect of this physically debilitating and unpredictable disease is explored. Guidance is offered on how the nurse should address the individual needs of patients and the importance of regular monitoring to ensure safety and efficacy of treatments. The need for effective patient education is emphasised to ensure the person is better able to manage disease progression and any treatment regimens. The nurse's role should be viewed in the context of the multidisciplinary team to ensure all patient needs are met.

Download full-text PDF

Source
http://dx.doi.org/10.7748/ns2012.08.26.52.35.c9247DOI Listing

Publication Analysis

Top Keywords

psoriatic arthritis
8
care support
4
support patients
4
patients psoriatic
4
arthritis psoriatic
4
arthritis inflammatory
4
disease
4
inflammatory disease
4
disease joints
4
joints associated
4

Similar Publications

Introduction: Leprosy is a chronic granulomatous disease caused by  and . Meanwhile, leprosy reactions are immunologically mediated episodes of acute or subacute inflammation that occur during the chronic course of the disease. Leprosy and leprosy reaction have a wide range of clinical manifestations, including those resembling psoriatic arthritis.

View Article and Find Full Text PDF

Objectives: Describe patterns of pharmacotherapy and psychological treatment and evaluate receipt of minimally adequate treatment for incident depression and anxiety in individuals with inflammatory arthritis (IA).

Methods: We used population-based linked administrative health databases from British Columbia, Canada to evaluate pharmacotherapy and psychological treatments for incident depression and/or anxiety among individuals with IA and without IA ('IA-free controls'). We defined minimally adequate pharmacotherapy as antidepressant prescriptions filled with ≥ 84 days' supply and adequate psychological treatment as ≥ 4 counselling/psychotherapy services.

View Article and Find Full Text PDF

Background: Despite the well-documented immune dysregulation in both psoriasis and Sjögren's syndrome (SS), the specific link between these two autoimmune diseases has not been extensively explored. The present study aims to investigate the impact of psoriasis on the risk of SS.

Methods: A retrospective cohort study using TriNetX data compared SS development in patients with psoriasis and controls using propensity score matching, Kaplan-Meier curves, and Cox models.

View Article and Find Full Text PDF

[Análisis de genotipos, alelos y haplotipos de HLA en un grupo de pacientes con artritis psoriásica: poca frecuencia de alelos comunes].

Biomedica

December 2024

Servicio de Reumatología e Inmunología, Hospital Militar Central, Bogotá, D. C., Colombia; Grupo de Inmunología Clínica Aplicada, Hospital Militar Central, Universidad Militar Nueva Granada, Bogotá, D. C., Colombia; Grupo de Inmunología Celular y Molecular - InmuBo, Universidad El Bosque, Bogotá, D. C., Colombia.

Unlabelled: Introducción. La artritis psoriásica es una enfermedad compleja y los antígenos leucocitarios humanos (Human Leukocyte Antigen, HLA) son un factor clave en el desarrollo de la enfermedad. En Latinoamérica, hay pocos datos sobre dichos antígenos en pacientes con artritis psoriásica.

View Article and Find Full Text PDF

Objective: To assess CXC chemokine receptor 5 (CXCR5) circulating DNA methylation differences in autoimmune rheumatic diseases and their relation with clinical features.

Methods: Targeted methylation sequencing was performed using peripheral blood from 164 rheumatoid arthritis (RA), 30 systemic lupus erythematosus (SLE), 30 ankylosing spondylitis (AS), 30 psoriatic arthritis (PsA), 24 Sjögren's syndrome (SS) patients, and 30 healthy controls (HC).

Results: Significant differences in CXCR5 cg19599951 methylation were found between RA and HC, as well as AS and SLE.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!